Infectiouse diseases
Conditions
Interventions
None listed
Sponsors
Disease Control and Prevention Center (DCC), National Center for Global Health and Medicine (NCGM)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who are 20 years or over and a Japanese national 2) Patients who are prescribed carbapenems and cephamycin/oxacephem antibiotics in the department of infectious diseases, general internal medicine, emergency medicine, or critical care of the NCGM 3) Patients who will continuously take antibiotics for more than 3 days, including the first day of taking the antibiotics
Exclusion criteria
Exclusion criteria: 1) Patients who have used antibiotics during the past 2 months 2) Patients who need to take carbapenems and cephamycin/oxacephem antibiotics together with other antibiotics 3) Patients to whom rectal swab sample collection cannot be applied e.g., patients with a stoma 4) Patients who have had a colectomy 5) Patients with a history of any hypersensitivity to carbapenems and cephamycin/oxacephem antibiotics 6) Patients whom the investigator deemed to be inappropriate for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The composition ratio of each type of microbes and that of functional genes of microbiomes | — |
Countries
Japan
Contacts
Public ContactSho Saito
National Center for Global Health and Medicine (NCGM) Disease Control and Prevention Center (DCC)
Outcome results
None listed